Giant Cell Arteritis

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: closed (1 November 2023) | Viewed by 160

Special Issue Editor


E-Mail Website
Guest Editor
Centre for Rheumatology and Connective Tissue Diseases, Royal Free Hospital, UCL Division of Medicine, London NW32QG, UK
Interests: understanding inflammatory fibrosis in order to develop new treatments
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Giant cell arteritis (also called temporal arteritis, GCA) is a significant and highly prevalent large vessel vasculitis affecting elderly Caucasian populations. Various clinical manifestations include headaches of varying severity and location, jaw claudication through the ischaemia of masseters, cervical and brainstem features through vertebra-basilar involvement, and visual loss, which can be permanent and bilateral. Due to this latter complication, GCA carries the highest medicolegal cost burden for both primary care and rheumatology specialists. Various models have been proposed to account for the disease, including immunogenetic background, ageing, and environmental damage to the cranial arteries followed by innate and adaptive cellular infiltration from the adventitia to the internal elastic lamina of affected cranial arteries. Advances in imaging include using FDG-PET scanning to show a characteristic aortic arch and subclavian pattern and using ultrasound imaging to reveal the halo sign around affected temporal arteries. Tissue sampling of the temporal artery remains the gold standard for diagnosis on which to base therapies such as high-dose steroids, synergising DMARDs, and more recently introduced biologics, such as IL-6 pathway inhibitors. However, this condition remains challenging to diagnose with certainty and treat without causing significant off-target effects.

Dr. Richard Stratton
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • large vessel vasculitis
  • aging
  • macrophage

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop